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Abstract
Background: The response to hypoxia in tissues is regulated by the heterodimeric transcription factor Hypoxia Inducible
Factor-1 (HIF-1).
Methodology/Principal Findings: We have created a strain of mice with inducible cardiomyocyte-specific expression of a
mutated, oxygen-stable, form of HIF-1a. Cardiac function steadily decreased with transgene expression, but recovered after
the transgene was turned off. Using long-oligo microarrays, we identified 162 transcripts more than 3-fold dysregulated in
these hearts after transgene expression. Among the down-regulated genes the transcript for SERCA was reduced 46% and
the protein 92%. This led us to an evaluation of calcium flux that showed diminished reuptake of cytoplasmic calcium in
myocytes from these hearts, suggesting a mechanism for cardiac dysfunction.
Conclusions/Significance: These results provide a deeper understanding of transcriptional activity of HIF in the heart, and
show that enhanced HIF-1 activity is sufficient to cause contractile dysfunction in the adult heart. HIF is stabilized in the
myocardium of patients with ischemic cardiomyopathy, and our results suggest that HIF could be contributing directly to
the contractile dysfunction in this disease.
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Introduction
HIF-1 is a heterodimeric transcription factor that regulates a
wide range of angiogenic, metabolic, and oxygen transport related
genes [1]. While the HIF-1b subunit, also known as the aryl
hydrocarbon receptor nuclear translocator, (ARNT) is a constitu-
tively expressed protein, HIF-1a is rapidly degraded in normoxic
conditions [2]. In hypoxic conditions, HIF-1a is stable and can
bind to HIF-1b [2] to form a dimer that binds to the hypoxia
response element (HRE) in HIF-1 regulated genes [3]. The
destabilization of HIF-1a by oxygen is understood in detail. In
normoxic conditions, two proline residues (Pro402 and Pro564)
[4], are hydroxylated by specific prolyl hydroxylases [5–8]. These
hydroxylated sites are recognized by the von-Hippel Lindau tumor
suppressor (pVHL)[8], which ultimately leads to proteosomal
degradation [5,9–15]. Another oxygen dependent control acting to
limit the activity of HIF-1a involves hydroxylation of an
asparagine residue (Asn803) by Factor Inhibiting HIF (FIH) [16–
18]. This prevents the HIF-1a C-terminal activation domain from
interacting with the transcriptional co-activating protein p300
[16], in turn limiting the transcriptional activity of HIF-1 in a
normoxic environment [19].
To study the action of HIF-1 in a normoxic environment, it
would be useful to disable this oxygen-related regulation.
Substitution of Pro564 and Pro402 abrogates HIF-1a/pVHL
interaction [8] and the subsequent ubiquitinylation and degrada-
tion of HIF-1a [6,20]. It has also been shown that enhanced
transcriptional activity, due to association of HIF-1a to p300, is
obtained in a normoxic environment by double substitution of
Pro564 and Asn803 with alanine [16].
For our studies we have created a transgenic mouse line to
directly test the effect of HIF-1a in the hearts of adult animals in a
normoxic environment. A transgene containing the human HIF-
1a cDNA with alanine substitutions at Pro402, Pro564, and
Asn803 (denoted HIF-1a-PPN), was generated. Since VEGF is
upregulated by HIF-1a [21] and VEGF overexpression during
fetal [22] and postnatal [23] stages of development is lethal, we
used a tetracycline inducible construct (tet-off system) to obtain
tight exogenous regulation of transgene expression. This also
allows us to investigate the effects of enhancing HIF-1 activity in
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modeling the potential use of HIF-1a for therapy of ischemia.
We then evaluated the resulting cardiac phenotype and explored
the underlying biochemical, physiological, and transcriptional
results of HIF-1 stabilization.
Recently, others have shown that a knock-out of the gene for the
Von Hippel Lindau protein, which should also lead to stabilization
of HIF, also causes depressed ventricular function [24]. The
ventricular dysfunction is ameliorated in a strain with a knock-out
of HIF-1a, further implicating HIF in the dysfunction. This
absence of VHL, occurring throughout the life of the animal,
causes damage to the myocardium that leads to a dilated
cardiomyopathy with a variety of marked histological findings
including lipid accumulation, myocyte loss, fibrosis, and even
malignant transformation. We do not see similar changes with
brief expression of HIF in the adult, but do find remarkable
angiogenesis and ventricular dysfunction, which is readily
reversible with cessation of transgene expression. Deletion of
Prolyl Hydroxylase 2 (PHD2), the enzyme thought to be most
important for HIF-1a degradation, also leads to reduced
contractility [25] suggesting that stabilization of HIF may impair
cardiac function, although other effects of prolyl hydroxylation
could be contributing to this effect.
Other studies suggest that exogenous HIF-1 can mediate
potentially beneficial effects on vascular growth [26]. In a
conventional, unregulated, transgenic model, HIF-1a expression
has recently been shown to attenuate cardiac dysfunction following
myocardial infarction [27] and it seems reasonable that a
transcription factor that responds to decreased oxygen delivery
would ameliorate the repercussions of hypoxia by improving blood
delivery and modulating oxidative metabolism. Nonetheless,
several lines of evidence point to an early decrement in ventricular
function mediated by HIF. Interestingly, the condition of ischemic
cardiomyopathy would be expected to stabilize HIF [28], which
could thereby contribute to the ventricular dysfunction of this
common cardiac disorder. It is a clinical observation that the
degree of ventricular dysfunction in ischemic cardiomyopathy is
often not closely related to the severity of epicardial coronary
disease. Perhaps this discordance is a function of the stabilization
of HIF, which would relate to the degree of hypoxia in living
cardiac myocytes, rather than the amount of damage wrought by
previous infarction. The reversible nature of the defect after HIF
induction suggests the potential contractile benefit that might
accrue from strategies directed towards relief of ischemia. Our
model has also allowed us to identify altered calcium handling as
one of the principal defects contributing to ventricular dysfunction
in this model, and a potential target for therapeutic manipulation.
Results
Biological Activity of HIF-1a-PPN
The transcriptional activity of the mutated HIF-1a was assessed
by co-transfection of the HIF-1a-PPN expression plasmid with an
HRE-luciferase reporter construct into HeLa cells. Co-transfection
of a plasmid containing wild-type HIF-1a caused negligible
induction of the HRE-luciferase reporter system under normoxic
conditions. However, increasing amounts of HIF-1a-PPN under
normoxic conditions induced luciferase activity to levels compa-
rable to those obtained from the wild-type protein under hypoxic
conditions (Table 1).
HIF-1a-PPN was also tested for its ability to elicit authentic
HIF-1a transcriptional regulation in our anticipated target cell
types, endothelial cells and cardiac myocytes. SV-40 transformed
mouse vascular endothelial cells (SVEC) and neonatal rat cardiac
myocytes were infected with either AdCMV-HIF-1a-PPN or
AdCMV-GFP. HIF-1a-PPN was robustly expressed in the SVEC
cells under normoxic conditions (not shown). The transcript for
VEGF-A, a known target gene of HIF-1a, was measured by real-
time PCR. HIF-1a-PPN expression produced increased abun-
dance of the endogenous VEGF-A transcript in both SVEC cells
and cardiac myocytes (Figure 1).
Conditional Expression of HIF-1a-PPN in Transgenic Mice
Initially, HIF-1a transgene expression in the hearts of tTA/
HIF-1a-PPN mice was verified by removing doxycycline from
drinking water for 14 days. Immunoprecipitation of HA tagged
HIF-1a-PPN from heart protein lysates demonstrated expression
of the transgene (Figure 2A). Importantly, tTA/HIF-1a-PPN mice
maintained on doxycycline showed no band on the Western blot,
indicating tight control of HIF-1a-PPN expression. Doxycycline
was then withdrawn from tTA/HIF-1a-PPN mice for 3, 5, and 7
days to test when the HIF-1a-PPN transgene was maximally
expressed. Western blotting of immunoprecipitated HIF-1a-PPN
demonstrated that the abundance of transgenic protein is
essentially maximal by 3 days (Figure 2B). Similarly, real-time
Table 1. Luciferase activity for increasing WT and HIF-1a-PPN
transfection compared to that expressed in normoxic and
hypoxic conditions.
Induction
DNA [ng]
WT HIF-1a
transfection
HIF-1a-PPN
transfection normoxia hypoxia
1 104.9
1 0.1 3.7
3 1 17.8
10 1 30.7
30 3 87.5
100 0.1 58.8
Each number represents the average of three independent measurements,
normalized to normoxia. WT: wildtype.
doi:10.1371/journal.pone.0011693.t001
Figure 1. VEGF expression in SVEC and cardiomyocyte cell
culture 72 hrs after infection with adenoviruses encoding HIF-
1aPPN or GFP.
doi:10.1371/journal.pone.0011693.g001
HIF-1a and Cardiomyopathya
PLoS ONE | www.plosone.org 2 July 2010 | Volume 5 | Issue 7 | e11693PCR determined that HIF-1a-PPN mRNA levels reached a peak
by 3 days after doxycycline omission, with no further increase after
7 days of doxycycline withdrawal (data not shown).
Ventricular function of tTA/HIF-1a-PPN Mice
Echocardiographic analysis of tTA/HIF-1a-PPN mice 14 days
after doxycycline withdrawal showed marked dilation of the left
ventricle (LVEDD: 3.0560.4 mm vs. 2.0960.06 mm; p=0.007),
a substantial decline in fractional shortening (3665% vs. 7365%;
p=0.0004; Figure 3A), but only a modest and statistically non-
significant increase in posterior wall thickness (0.8860.1 mm vs.
0.9760.1 mm; p=0.21). Even after only 3 days of HIF-1a-PPN
expression, ventricular function was impaired in tTA/HIF-1a-
PPN vs. tTA mice (fractional shortening decreased to 4465% vs.
6565%; p=0.0004). Importantly, after doxycycline was restored
to the drinking water for 7 days ventricular function returned to
normal (Figure 3B).
Morphological analyses of hearts
Following removal of doxycycline from the drinking water,
heart weight to body weight ratio size increased significantly
(Figure 4). On initial macroscopic inspection, remarkably large
epicardial vessels with prominent side branches were observed
(Figure 4). The myocardium showed no obvious abnormality,
specifically no heterogeneity in myocyte size, hypertrophy, or
scarring, that might suggest myocyte death contributing to the
ventricular dysfunction. Additionally, histological evaluation of the
heart by hematoxylin and eosin or trichrome staining demon-
strated no obvious pathology due to HIF-1a-PPN over-expression
(Figure 5). TUNEL staining also showed no appreciable
differences over twenty-eight days of HIF-1a-PPN expression
(data not shown).
Reversibility Study
After 7 days of removal of doxycycline followed by restoration of
inhibition of the tet-transactivator protein for 7, 14 and 21 days, the
heart weight to body weight ratio decreased gradually (7 day
0.007060.0016; 14 day 0.005260.0008 and 21 day 0.005560.0013)
towards the ratio seen in the on-doxycycline control
(0.004760.0002). Re-inhibition of HIF-1a-PPN expression was
associated with an increase in SERCA protein in the myocardium
(Figure 6). Full restoration to baseline levels was observed 14 days
after doxycycline was restored, and this recovery was maintained
through 21 days. The return of SERCA was temporally correlated
with a restoration of cardiac function assessed by echocardiogram (see
above). HIF protein levels decreased gradually after doxycycline was
restored (to 41%64% of baseline after 21 days), decreasing at a rate
slower than SERCA restoration (Figure 6).
Cardiac gene regulation after expression of HIF-1a-
PPN. Analysis of gene regulation by microarray analysis
revealed a large number of genes that were both up- and down-
regulated (.3-fold) after HIF-1a-PPN expression for either 1 day
or 3 days (GEO reference GPL7119). The abundance of the
message for 126 genes was more than 3-fold increased after 1 day
of HIF expression in the heart. 213 genes were up-regulated at 3
days and 38 genes were common to both time-points (Figure 7A).
Thirty-seven genes were down-regulated more than 3-fold at day 1
and 100 at day 3, with 3 common to both (Figure 7A). Inspection
of the twenty most highly up-regulated genes at day 1 or day 3 of
transgene expression showed no significant difference in the
frequency of evolutionarily conserved HRE core sites (data not
shown, p=0.75). The expression levels of 19 notable and highly
regulated transcripts from the array analysis were further
confirmed by real-time PCR. Results from the real-time PCR
experiments are shown in Figure 7B. As expected, the message for
VEGF-A is approximately 2-fold more abundant. The other
regulated genes shown in Figure 7B can be characterized as
functioning in metabolism (Car9; Gstm5; Scd1; Slc27a1, Ucp1,
Eno1; Gpi1; Pfkp), prolyl hydroxylation (Egln3), replication/
transcription (Bazf; Mki67; Mcmd6; Mcmd7; Paip1), and other
miscellaneous, or uncharacterized functions (Fscn1; RP23-
427P14.1, Plunc, Ift122). In summary, we find that the
abundance of mRNA from a large number of genes vital to
glycolysis are increased, whereas the majority of mRNAs for genes
necessary for oxidative phosphorylation are less abundant.
Figure 2. Western blot of anti-HA immunoprecipitated HIF-1a-PPN from mouse hearts induced by doxycycline withdrawal for (A)
14 days and (B) 3, 5, and 7 days. Each lane contains cardiac lysate from a different animal.
doi:10.1371/journal.pone.0011693.g002
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focused on the transcription of genes important for calcium handling
in the cardiomyocytes, showed that the mRNA for the sarcoplasmic
endoplasmic reticulum calcium ATPase (SERCA) pump is half as
abundant after 72 hours of induction of HIF-PPN (Figure 8). We also
saw reduced abundance of the mRNA for phospholamban (PLB) and
the type-2 ryanodine receptor (RYR2) (Figure 8).
Chromatin immunoprecipitation
Chromatin immunoprecipitation identified direct binding of
HIF-1a to six of the nineteen genes found to be dysregulated by
real-time PCR and microarray analyses (Supplemental Table S1).
An additional thirty genes, directly regulated by HIF-1a-PPN,
have also been confirmed by both ChIP and microarray analyses
(Supplemental Table S1).
ATP:ADP ratio
The transcriptional evaluation suggests an important (and expected)
shift in metabolism from oxidative to glycolytic metabolism,
permitting continued function with reduced oxygen consumption.
Based on this consideration, we evaluated whether the ventricular
dysfunction we saw could be the result of a defect in metabolism due to
an inappropriate shift from oxidative phosphorylation to less efficient
glycolysis. Surprisingly, despite the shift to potentially less efficient
ATP production, the ATP:ADP ratio increased after HIF induction
(Figure 9). This is primarily due to an increase in the available ATP
within the myocardium, coupled with a relatively unchanged ADP
concentration. We then considered the possibility that the cardiac
dysfunction was not caused by reduced ATP availability, but
conversely, that the changes we observed in ATP concentration
resulted from reduced ATP utilization due to reduced contractility.
Specifically, we considered the possibility that the HIF response,
rather than reducing oxygen demand in the myocardium, was
conserving ATP as a temporary measure to maintain viability during
transient hypoxic episodes. We evaluated key players in excitation-
contraction coupling in the heart to determine whether HIF-directed
modification of this pathway could explain the loss of contractility.
Direct measure of calcium flux
Our transcriptional evaluation did indeed demonstrate substantial
down-regulation of the mRNA for SERCA. The abundance of
cardiac SERCA mRNA was reduced 2-fold after 3 days of transgene
expression and SERCA proteinwas reduced to an even greaterdegree
(Figure 10). If re-uptake of calcium is depressed by reduced SERCA
amount or activity, then reduced inotropy would be expected. We did
find that Ca
++ uptake was impaired after 7 days of oxygen-stable HIF
expression and therefore ascribe at least a portion of the ventricular
dysfunction to this cause. To quantify this slowed reuptake, the decay
in calcium fluorescence was fit to an exponential decay model (see
Method’s section for further detail), and a quantity, t, representing the
time constant of decay, could thus be calculated. A higher value of t is
representative of slower calcium uptake. We found that t increased
from 312 +/2 39 ms to 526 +/2 35 ms, indicating the expected
impairment of reuptake of Ca
++ by SERCA.
Discussion
We have created a transgenic model that allows the regulated
expression of constitutively active HIF-1a in the adult myocardi-
um. These animals allow us to identify the genes that are regulated
Figure 3. Echocardiographic fractional shortening of tTA/HIF-1a-PPN vs. tTA mouse hearts at (A) 0, 3, 7, and 14 days after
doxycycline removal and (B) after 3 days of transgene induction followed by 7 days of recovery.
doi:10.1371/journal.pone.0011693.g003
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anatomic effects of HIF expression.
During HIF-1 expression in adult transgenic mice, ventricular
function deteriorated and the heart dilated. Importantly, ventric-
ular function returned to normal 7 days after transgene expression
was terminated, indicating that the decrease in ventricular
function was reversible and not related to irrevocable myocyte
death. A recent study utilizing a cardiac-specific VHL KO 2/2
mouse also demonstrated a decline in ventricular function,
manifesting at three months of age, that was prevented by an
additional deletion of HIF-1a [24]. Taken together, our findings
and these support the direct role of HIF-1a transcriptional activity
in ventricular dysfunction, although it is certainly possible that the
other study reflects activities of HIF during development or
growth, that impair contractility by a distinct mechanism.
Our model allows us to examine the earliest gene regulation
induced by HIF in vivo. These early genes are likely to be directly
regulated by HIF, and thus provide insight into the pathways that
transduce HIF effects. As seen in previous in vitro studies [29,30], the
mRNAs for several glycolytic enzymes, particularly Eno1 and Pfk,
were up-regulated. HIF-1a-PPN expression also induced indicators
of cellular proliferation, including Mki67 and Mcmd6 mRNAs.
These transcriptsmay be related to the observed angiogenic response,
occurring in the endothelial cells and pericytes recruited to new
vessels. Several cancer-related transcripts were found to be up-
regulated as well, including the mRNA for actin-bundling protein
Fscn-1 (reviewed in [31]). Bcl-6, a homolog of the up-regulated Bazf
gene, has been found to be up-regulated in breast cancer and
associated with higher HIF-1alevels[32]. Many of the HIF-regulated
genes in this study have not been previously recognized to be related
to hypoxia, and their putative roles in the hypoxic response will
require more evaluation.
The HIF-induced changes in mRNA abundance that we
observe are consistent with the anticipated shift from oxidative
Figure 4. Changes in heart weight and epicardial vessels after HIF expression. (A) Heart weight to body weight ratio following doxycycline
removal. (B) Macroscopic view of tTA heart compared to HIF/tTA seven days after doxycycline removal. Arrows point to epicardial blood vessels that
are much more prominent after.
doi:10.1371/journal.pone.0011693.g004
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a reduction in the abundance of the mRNAs for key components
of excitation-contraction coupling. In particular, we have observed
reduced abundance of the mRNA for the SERCA2a calcium
pump, as well as transcripts for PLB and RYR2. Down-regulation
of these three genes would be predicted to produce a reduction in
contractility in the heart due to a reduced calcium gradient across
the SR membrane, and a reduced release of calcium upon
initiation of contraction through the RYR2 channel. We propose
that the heart cannot maintain normal contractility because of
reduced expression of the SERCA pump, with resulting slowed re-
uptake of cytoplasmic Ca
++. Our direct measurement of calcium
flux supports this mechanism.
In human hearts there is strong evidence for down-regulation of
SERCA in ischemia[33]and heart failure[34]. There is an ongoing
effort to develop methods to treat heart failure by modulating
SERCA and other components of Ca regulation[35]. Our data
further emphasizes the importance of reduced SERCA as a
primary effector of cardiac contractility, and therefore a worthy
target for such strategies. It is interesting in this regard that the
gene for SERCA has several potential hypoxia response elements
in its promoter and that the response to the single stimulus of HIF
induction is rapid. Both observations suggest that HIF-may be
directly regulating SERCA, although this promoter was not
identified among the ChIP positive fragments.
The paradoxical change in the ATP:ADP ratio suggests that the
upregulated glycolytic pathway is able to maintain ATP stores.
Reduced calcium cycling from the sarcoplasmic reticulum, which
we expect with reduced SERCA, could be responsible for both
reducing contractility and maintaining the ATP:ADP ratio by
reducing ATP consumption during the cardiac cycle.
In patients with ischemic cardiomyopathy, PET studies have
demonstrated that hibernating myocardium, defined as areas of
the heart with reduced blood flow but maintained glucose
utilization, is less common than ‘‘stunned’’ myocardium with
preserved blood flow. Nonetheless, 9% of dysfunctional segments
in such patients show the reduced perfusion, (with preserved
glucose metabolism), that would be expected to lead to chronic
HIF stabilization [36]. Parenthetically, it may be that the shift to
glycolysis expected with HIF action is playing a role in preserving
glucose utilization in these segments of underperfused heart. If
HIF is stabilized in these segments it could be responsible for the
impaired contractility, as seen in our mouse model [28].
Our findings suggest that a portion of the reduced contractility
in ischemic cardiomyopathy could be directed by HIF. Our model
allows us to study HIF in isolation from other transcription factors
that may be active during an ischemic insult. The data presented
here suggest that HIF, acting alone upon the heart, causes cardiac
dysfunction. The mechanism is at least in part mediated by
reduction in calcium reuptake into the sarcoplasmic reticulum.
A limitation of our approach is that we have examined the
action of HIF in normoxic tissue, whereas the authentic in vivo
action of HIF will occur predominately in hypoxic tissue where
redox potential, pH, and substrate utilization may modify the
transcriptional activity of HIF. However, the in vivo effects that we
see are almost certainly more authentic than those obtained in cell
culture, and seem likely to accurately recapitulate effects of human
cardiac ischemia that occurs in mature adults.
The principal finding of this study, the unexpected, reversible,
decrement in ventricular function, must be considered in any effort
at HIF-1a-directed therapy. Perhaps of even greater clinical
significance, this finding suggests a novel mechanism for ischemic
cardiomyopathy. If persistent ischemia produces chronic HIF
stabilization in even a portion of the ischemic heart, then the
action of this transcription factor, perhaps acting in trans through
downstream intra-cardiac signaling pathways, could directly
impair ventricular performance. An exciting ramification of this
hypothesis is that new therapy directed at HIF action could
ameliorate this dysfunction.
Methods
Transgenic animal generation
Ethics Statement. All animals were handled in accordance
with good animal practice as defined by the relevant national and/
or local animal welfare bodies, and all animal work was approved
by the appropriate committee (University of Hawaii Institutional
Animal Care and Use Committee, approval number 06-011-4).
PCR-based mutagenesis was used to create a mutated human
Figure 5. Representative histology of HIF-1a-PPN expressing hearts. Top panels: hematoxylin and eosin; Lower panels: trichrome, Scale bar: 50 mm.
doi:10.1371/journal.pone.0011693.g005
Figure 6. Western blot of HIF-1a-PPN and SERCA levels
following doxycycline restoration.
doi:10.1371/journal.pone.0011693.g006
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HIF-1a-PPN) that was cloned into the pcDNA 3.1 vector
(Invitrogen, Carlsbad, CA). A hemagglutinin (HA) tag was
added after the last c-terminal codon using a linker (between
Hpa I and Xba I). This plasmid was used for transfection of tissue
culture cells, as well as for production of an adenoviral vector
encoding HIF-1a-PPN under the regulation of the
cytomegalovirus (CMV) promoter. The HA-tagged HIF-1a-PPN
cDNA was subcloned into the tetracycline-responsive pUHG-10
vector to generate the pUHG-HIF-1a-PPN vector. DNA was
injected into B6C3F1 mouse oocytes and implanted into surrogate
female ICR mice. Founder mice were identified by PCR with a
reverse primer located in the HA-tag. Transgenic offspring were
bred to a second transgenic line containing the tetracycline trans-
activator region fused downstream of the cardiac-specific a-myosin
heavy chain (aMHC) promoter [the generous gift of Dr. Glen
Fishman]. Double transgenic mice (tTA/HIF-1a-PPN) were
maintained on 200 mg doxycycline per ml of 2.5% sucrose-water
Figure 7. Transcriptional regulation by cardiac HIF. (A) Venn diagram of genes regulated .3-fold in the heart as determined by microarray. (B)
RT-PCR Gene expression results for tTA/HIF-1a-PPN mice compared to tTA control mice.
doi:10.1371/journal.pone.0011693.g007
Figure 8. Semi-quantitative real-time PCR analysis of transcript abundance in hearts after HIF induction. Metabolism-related genes
showing the expected up-regulation of glycolytic genes and down-regulation of genes involved in oxidative metabolism. Evaluation of select genes
involved in calcium cycling shows down-regulation of SERCA, along with moderate down-regulation of RYR-2 and PLB.
doi:10.1371/journal.pone.0011693.g008
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doxycycline from conception to 6 weeks. Thereafter, doxycycline
was omitted for varying periods to assess experimental effects of
the mutant HIF-1a transgene. All experiments used 6 to 8 week
old male mice.
HIF-inducible luciferase assay
Constitutive normoxic induction of the HIF-1a-PPN mutant
was assessed by transient transfection of HeLa cells with increasing
amounts of either a wild-type HIF-1a expression vector or the
PPN expression vector. HIF activity was measured by induction of
a HIF-inducible luciferase reporter driven by three tandem HIF
response elements [3HRE-tk-luc[37]]. Activity of this promoter
following hypoxic induction of endogenous HIF (15 h at 1% O2)
was used to assess maximal endogenous regulation. Luciferase
activity was measured using Luciferase Reporter Assay System
(Promega, Madison, WI), following manufacturer’s instructions,
20 hrs following transient transfection using the Lipofectamine
PLUS reagent (Invitrogen, Carlsbad, CA).
In vitro experiments using an adenoviral vector
An adenoviral vector encoding the HA-tagged cDNA of HIF-
1a-PPN under the control of a CMV promoter was generated
(AdCMV-HIF-1a-PPN). The virus was used to transfect cultured
mouse endothelial cells (SVEC) and rat neonatal cardiac myocytes
to evaluate expression of the protein by Western blotting. Plates
with 1.3610
6 cells were incubated with 200 pfu/cell of AdCMV-
HIF-1a-PPN or the same amount of AdCMV-pLpA (no cDNA) as
a control. Cells were harvested after 72 h and total protein lysates
were prepared. Western blots were performed after isolation and
concentration of the protein by magnetic immunoprecipitation.
The abundance of the VEGFa mRNA was determined by real-
time PCR.
Chromatin Immunoprecipitation Assays (ChIP)
After one or three day induction of the transgene, DNA from
individual mouse hearts (n=3 for each time point) was subjected
to magnetic-ChIP (Millipore, Billerica, MA), according to
manufacturers protocol, using an antibody to the HA tag.
Fragments immunoprecipitated from the ChIP assay were ligated
into pZEr0-1 plasmids, cloned into TOP 10 E.coli (all Invitrogen,
Carlsbad, CA), and sequenced using plasmid-specific T7 sequenc-
ing primers. Resulting sequence was mapped to the mouse
genome (UCSC genome browser, July 2007), following nucleotide
BLAST analyses (NCBI).
Immunoprecipitation and Western Blotting
Individual whole mouse hearts were homogenized in RIPA-
buffer and incubated for 1 h at 4uC. Following centrifugation,
500 ml of the supernatant was cleared by magnetic immunopre-
cipitation using a commercial kit with anti-HA-microbeads
according to the manufacturer’s protocol (Miltenyi Biotec,
Auburn, CA). Western blots were performed with either a primary
monoclonal anti-HA antibody (100 ng/ml) (Roche, Mannheim,
Germany), a monoclonal anti-human-HIF-1a antibody (1:500)
(Novus Biologicals, Littleton, CO), or a monoclonal goat anti-
SERCA2 antibody (1:1,000) (Santa Cruz, Santa Cruz, CA). After
incubation with a secondary peroxidase-conjugated antibody (for
HA and HIF-1 a), or AlexFluorH-568-conjugated antibody (for
SERCA2) (Invitrogen, Carlsbad, CA), blots were developed using
a commercial substrate (SuperSignal West Pico, Pierce, Rockford,
IL) and visualized with a Typhoon scanner (GE Lifesciences,
Piscataway, NJ) (535 nm excitation, 560LP emission, 500PMT).
ImageJ software was used for densitometry analyses.
Echocardiography
We evaluated left ventricular function in unsedated mice with
transthoracic echocardiography (Sonos 5500 machine, Philips,
Andover, MA) using a S12 transducer (12 MHz). We examined
both tTA/HIF-1a-PPN and tTA mice at various times after
omitting or adding back doxycycline (n=4 for each strain at each
time point). Left ventricular parasternal short-axis views were
obtained in M-mode imaging at the level of the papillary muscle.
Two consecutive beats in three M-mode images (6 beats total)
Figure 9. Effect of HIF expression on cardiac ATP:ADP ratio. Progressive increase in ATP:ADP ratio was observed after doxycycline was
withheld in the hearts of HIF/tTA mice. (n= three hearts per time point).
doi:10.1371/journal.pone.0011693.g009
HIF-1a and Cardiomyopathya
PLoS ONE | www.plosone.org 8 July 2010 | Volume 5 | Issue 7 | e11693Figure 10. SERCA protein levels and calcium reuptake after HIF expression. (A) SERCA western blot. SERCA is markedly reduced after even
a single day of transgene induction; the western blot below the graph shows results from two animals at each timepoint. (B) Calcium reuptake in
cardiomyocytes is slower after transgene induction.
doi:10.1371/journal.pone.0011693.g010
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internal diameter (LVEDD), left ventricular end-systolic internal
diameter (LVESD), and posterior wall thickness (PWT). Fractional
shortening (FS) was calculated as FS%=[(LVEDD-LVESD)/
LVEDD]6100.
Reversibility study
Mice were taken off doxycycline for 7 days, at which time three
hearts were harvested to assess activation of HIF-1a-PPN, and
doxycycline was returned to the drinking water of all remaining mice.
Three hearts were obtained at 7, 14 and 21 daysfollowingrestoration
of doxycycline. At the end of the experiment, control hearts from
mice that had been maintained on doxycycline were obtained. Whole
heart lysates were prepared as described above, and Western blot
analysis was performed to determine protein abundance of HIF-1a-
PPN and SERCA2. Protein abundance was quantified using
densiometry and was normalized to GAPDH abundance.
Immunohistochemistry and histology
Mice (n=3 for each evaluation) were deeply anesthetized with
Ketamine/Xylazine, then perfused with PBS by cardiac puncture
followed by fixation with 15 mL of 4% paraformaldehyde in PBS.
For paraffin-embedded tissue, hearts were removed and immersed
in 4% paraformaldehyde for 4 hours, then transferred to 70%
ethanol. Following dehydration through ethanol and transfer to
xylene, hearts were embedded in hot paraffin wax. Five mm
sections were cut with a microtome and kept on a heat block
overnight. Prior to staining, slides were deparaffinized in xylene
and rehydrated in an ethanol series.
For hematoxylin & eosin staining, slides were incubated in Gill
number 2 hematoxylin (Richard Allen Scientific) for 3 minutes,
rinsed under running tap water, then counterstained with eosin Y
(EMD) for one minute, and finally rinsed for one minute in acetic
water (0.1% glacial acetic acid in water). Masson’s trichrome
staining was performed using The Trichrome Modified Masson’s
Stain Kit (Scytek Labs), according to manufacturer’s instructions.
Following trichrome and H&E staining, slides were dehydrated in
an ethanol series, cleared in xylenes, and coverslipped with
Permount (Fisher) mounting medium.
RNA preparation, microarray analysis, and real-time PCR
Total RNA from mouse hearts was isolated with TRIzol reagent
(Invitrogen, Carlsbad, CA) according to the manufacturer’s
protocol. For microarray analysis, probes were generated from
reverse transcription of 20 mg of pooled RNA for each of tTA and
tTA/HIF-1a-PPN sample groups (n=3 per time point) with Cy3
and Cy5. Hybridization was performed overnight against arrays
containing the 32,000 murine long-oligo V3 collection (Qiagen,
Valenica, CA). A Genepix system (Axon Instruments, Union City,
CA) and Gene Traffic software (Iobion, La Jolla, CA) were used
for scanning and analyzing data, respectively.
For real-time PCR, cDNA was produced from each individual
heart (n=3 for each time point) to allow assessment of inter-
animal variation. Oligonucleotide primers were designed to cross
an intron. Real-time PCR was performed on cDNA representing
5 ng of total RNA. PCR was run in triplicate with QuantiTect
SYBR Green (Qiagen, Hilden, Germany) in an Opticon device
(MJ Research, Waltham, MA). Tangerin, which was unregulated
on initial array analyses, was used as an internal control.
HRE Scanning
Genes directly regulated by HIF-1 are likely to contain a core
HRE site 59-RCGTG-39 [30]. In order to evaluate whether or not
the genes regulated shortly after HIF expression were more likely
to contain such a canonical HRE, we examined the 20 most up-
regulated genes identified after 1 or 3 days of HIF expression. In
order to enhance the specificity of our survey, we focused on core
HRE binding sites that were conserved between the mouse and
human genomes. The rVista 2.0 program [38] was used to align
and scan each gene for potential conserved HRE core sites located
within non-coding regions between 2 kb upstream and 1 kb
downstream of the gene. We counted sites located within
evolutionarily conserved regions at least 100 base pairs in length
having at least 70% inter-species conservation. Additionally, local
conservation, evaluated as at least 80% identity in a 20 base-pair
sliding window containing the core site, was required of the
potential HRE sites. Significance was tested with Fisher’s exact
test.
ATP:ADP ratio
Whole heart cell lysates (n=3) were analyzed using a Bioassay
Systems Enzylight
TM ATP:ADP ratio kit (ELDT-100, Bioassay
Systems, Hayward, California). 5 mL of cell lysates, normalized to
a protein concentration of 5.0 mg/mL by Bradford analysis, were
treated with two compounds which generated light in direct
proportion initially to the concentration of ATP, and subsequently
to the sum of the ATP and ADP signal. The ratio between the two
compounds is calculated from the difference between the two
measurements, divided by the ATP signal. Luminometry was
assessed using a TD-20/20 Luminometer (Turner Designs,
Sunnyvale, California). RLU counts were integrated over 5
seconds, after a 2 second wait time.
Calcium Flux
After anesthesia, hearts (n=3) were excised from adult male
mice and flushed with a Tyrodes’ solution containing 100 mM
Ca
2+ through which 95% oxygen had been bubbled. The
ventricles were minced and digested with 300 mg/mL of Liberase
Blendzyme 2 (Roche) for 1 hour at 37 C with trituration every 5
minutes. Cells were then transferred to DMEM containing 10%
fetal calf serum to halt the enzymatic reaction. The cells were
plated onto laminin-coated glass-bottomed culture dishes (Mat-
TEK Corp., Ashland, MA). After 24 hours, the media was
replaced with DMEM solution containing 3.0 mM of Fluo-4
calcium indicator dye (Invitrogen, Carlsbad, CA). After one hour
of incubation, the cells were stimulated with 100 nM isoproter-
enol, and fluorescence intensity was measured along a line
perpendicular to the long axis of the cell at a frequency of 10 hz
using a Zeiss LSM-5 Pascal Laser Scanning Microscope (Zeiss,
Jena Germany). Fluorescence was measured on an arbitrary scale
where the background fluorescence was zero, and the maximum
measured fluorescence was equivalent to 1. A single-variable least-
squares algorithm was created to fit the fluorescence values to an
equation of the form: f=foe
t/t. Where f is the fluorescence at any
given time t, and f0 is the maximum fluorescence elicited during a
cardiac cycle. The activity of the SERCA pump is the primary
pathway by which calcium is removed from the cytoplasm.
Therefore, a higher calculated value of t corresponds primarily to
a reduced cellular activity of SERCA.
Supporting Information
Table S1 Select genes from microarray analyses confirmed by
ChIP assays.
Found at: doi:10.1371/journal.pone.0011693.s001 (0.06 MB
DOC)
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